Daemen T, Velinova M, Regts J, de Jager M, Kalicharan R, Donga J, van der Want J J, Scherphof G L
Groningen Institute for Drug Studies (GIDS), Department of Physiological Chemistry, Faculty of Medical Sciences, University of Groningen, the Netherlands.
Hepatology. 1997 Aug;26(2):416-23. doi: 10.1002/hep.510260223.
Liposomes with diameters of 200 to 400 nm containing phosphatidylserine (PS) or phosphatidylglycerol (PG) were injected intravenously into rats. Two hours after injection, 75% of the injected dose of PS liposomes was found in the liver and only 10% found in the spleen, while 35% of the PG liposomes was found in the liver and as much as 40% was found in the spleen. Cell-isolation experiments revealed the following remarkable difference in the intrahepatic distribution between the two liposome formulations: the PS liposomes distributed in about equal amounts to Kupffer cells and hepatocytes, despite their size (200-400 nm) exceeding that of the endothelial fenestrae (average 150 nm), whereas the PG liposomes were only taken up by the Kupffer cells and not at all by the hepatocytes. Double-label studies, using liposomes in which the lipid-moiety was radio labeled with [3H]cholesteryloleylether ([3H]CE) and the water phase with [14C]sucrose, showed that the liposomes were taken up as intact particles. These observations were confirmed through electron microscopy by determining the in situ localization of liposome-encapsulated colloidal gold particles in thin sections of liver and spleen. The differences in organ distribution are ascribed to differences in opsonization patterns of the two liposomal surfaces. For the difference in intrahepatic distribution, we offer the following two explanations: the exploitation of the blood cell-mediated forced sieving concept and the indication of a PS-specific pharmacological effect on the dimensions of the fenestrations.
将含有磷脂酰丝氨酸(PS)或磷脂酰甘油(PG)、直径为200至400纳米的脂质体静脉注射到大鼠体内。注射两小时后,发现注射剂量的75%的PS脂质体存在于肝脏中,只有10%存在于脾脏中,而35%的PG脂质体存在于肝脏中,高达40%存在于脾脏中。细胞分离实验揭示了两种脂质体制剂在肝内分布上的以下显著差异:尽管PS脂质体的大小(200 - 400纳米)超过了内皮窗孔的大小(平均150纳米),但它在库普弗细胞和肝细胞中的分布量大致相等,而PG脂质体仅被库普弗细胞摄取,肝细胞根本不摄取。使用脂质体进行的双标记研究表明,脂质体的脂质部分用[3H]胆固醇油醚([3H]CE)进行放射性标记,水相用[14C]蔗糖进行标记,结果显示脂质体作为完整颗粒被摄取。通过电子显微镜确定脂质体包裹的胶体金颗粒在肝脏和脾脏薄片中的原位定位,证实了这些观察结果。器官分布的差异归因于两种脂质体表面调理模式的差异。对于肝内分布的差异,我们提出以下两种解释:利用血细胞介导的强制筛分概念以及PS对窗孔尺寸的特异性药理作用的指征。